List of works - Sarwish Rafiq

CAR therapy for hematological cancers: can success seen in the treatment of B-cell acute lymphoblastic leukemia be applied to other hematological malignancies?

scientific article published on June 2015

Comparative assessment of clinically utilized CD20-directed antibodies in chronic lymphocytic leukemia cells reveals divergent NK cell, monocyte, and macrophage properties

scientific article published on 15 February 2013

Driving CAR T-cells forward

scientific article

Engineering strategies to overcome the current roadblocks in CAR T cell therapy

scientific article published on 17 December 2019

Excessive costimulation leads to dysfunction of adoptively transferred T cells

scientific article published on 25 March 2020

Genomewide DNA methylation analysis reveals novel targets for drug development in mantle cell lymphoma.

scientific article

Glycovariant anti-CD37 monospecific protein therapeutic exhibits enhanced effector cell-mediated cytotoxicity against chronic and acute B cell malignancies

scientific article published on 07 June 2013

Hsp90 Co-localizes with Rab-GDI-1 and regulates agonist-induced amylase release in AR42J cells

scientific journal article

Ibrutinib antagonizes rituximab-dependent NK cell-mediated cytotoxicity

scientific article published on March 2014

Inhibition of human erythrocyte invasion by Babesia divergens using serine protease inhibitors

scientific article published on 26 January 2007

Modeling anti-CD19 CAR T cell therapy in humanized mice with human immunity and autologous leukemia.

scientific article

Ocaratuzumab, an Fc-engineered antibody demonstrates enhanced antibody-dependent cell-mediated cytotoxicity in chronic lymphocytic leukemia

scientific article

Optimization of T-cell receptor-modified T cells for cancer therapy

scientific article published on 24 March 2020

Optimized T-cell receptor-mimic chimeric antigen receptor T cells directed toward the intracellular Wilms Tumor 1 antigen.

scientific article published on 7 December 2016

Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo

scientific article published on 13 August 2018

Tetraspanin CD37 directly mediates transduction of survival and apoptotic signals

scientific article

Tumor derived UBR5 promotes ovarian cancer growth and metastasis through inducing immunosuppressive macrophages

scientific article published on 08 December 2020

Tumors evading CARs-the chase is on

scientific article published on 01 October 2018

XmAb-5574 antibody demonstrates superior antibody-dependent cellular cytotoxicity as compared with CD52- and CD20-targeted antibodies in adult acute lymphoblastic leukemia cells.

scientific article published on 15 February 2012

List of works by Sarwish Rafiq

CAR therapy for hematological cancers: can success seen in the treatment of B-cell acute lymphoblastic leukemia be applied to other hematological malignancies?

Comparative assessment of clinically utilized CD20-directed antibodies in chronic lymphocytic leukemia cells reveals divergent NK cell, monocyte, and macrophage properties

Driving CAR T-cells forward

Engineering strategies to overcome the current roadblocks in CAR T cell therapy

Excessive costimulation leads to dysfunction of adoptively transferred T cells

Genomewide DNA methylation analysis reveals novel targets for drug development in mantle cell lymphoma.

Glycovariant anti-CD37 monospecific protein therapeutic exhibits enhanced effector cell-mediated cytotoxicity against chronic and acute B cell malignancies

Hsp90 Co-localizes with Rab-GDI-1 and regulates agonist-induced amylase release in AR42J cells

Ibrutinib antagonizes rituximab-dependent NK cell-mediated cytotoxicity

Inhibition of human erythrocyte invasion by Babesia divergens using serine protease inhibitors

Modeling anti-CD19 CAR T cell therapy in humanized mice with human immunity and autologous leukemia.

Ocaratuzumab, an Fc-engineered antibody demonstrates enhanced antibody-dependent cell-mediated cytotoxicity in chronic lymphocytic leukemia

Optimization of T-cell receptor-modified T cells for cancer therapy

Optimized T-cell receptor-mimic chimeric antigen receptor T cells directed toward the intracellular Wilms Tumor 1 antigen.

Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo

Tetraspanin CD37 directly mediates transduction of survival and apoptotic signals

Tumor derived UBR5 promotes ovarian cancer growth and metastasis through inducing immunosuppressive macrophages

Tumors evading CARs-the chase is on

XmAb-5574 antibody demonstrates superior antibody-dependent cellular cytotoxicity as compared with CD52- and CD20-targeted antibodies in adult acute lymphoblastic leukemia cells.